147 related articles for article (PubMed ID: 9731794)
1. Interleukin-6 derived from hypoxic myocytes promotes neutrophil-mediated reperfusion injury in myocardium.
Sawa Y; Ichikawa H; Kagisaki K; Ohata T; Matsuda H
J Thorac Cardiovasc Surg; 1998 Sep; 116(3):511-7. PubMed ID: 9731794
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations.
Sawa Y; Shimazaki Y; Kadoba K; Masai T; Fukuda H; Ohata T; Taniguchi K; Matsuda H
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):29-35. PubMed ID: 8551786
[TBL] [Abstract][Full Text] [Related]
3. Hypoxic stress induces cardiac myocyte-derived interleukin-6.
Yamauchi-Takihara K; Ihara Y; Ogata A; Yoshizaki K; Azuma J; Kishimoto T
Circulation; 1995 Mar; 91(5):1520-4. PubMed ID: 7867193
[TBL] [Abstract][Full Text] [Related]
4. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
[TBL] [Abstract][Full Text] [Related]
5. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass.
Wan S; DeSmet JM; Barvais L; Goldstein M; Vincent JL; LeClerc JL
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):806-11. PubMed ID: 8800171
[TBL] [Abstract][Full Text] [Related]
6. Blood cardioplegia supplementation with the sodium-hydrogen ion exchange inhibitor cariporide to attenuate infarct size and coronary artery endothelial dysfunction after severe regional ischemia in a canine model.
Muraki S; Morris CD; Budde JM; Zhao ZQ; Guyton RA; Vinten-Johansen J
J Thorac Cardiovasc Surg; 2003 Jan; 125(1):155-64. PubMed ID: 12538999
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil mediated damage to isolated myocytes after anoxia and reoxygenation.
Hansen PR; Stawski G
Cardiovasc Res; 1994 Apr; 28(4):565-9. PubMed ID: 7514099
[TBL] [Abstract][Full Text] [Related]
8. Serine protease inhibitor nafamostat given before reperfusion reduces inflammatory myocardial injury by complement and neutrophil inhibition.
Schwertz H; Carter JM; Russ M; Schubert S; Schlitt A; Buerke U; Schmidt M; Hillen H; Werdan K; Buerke M
J Cardiovasc Pharmacol; 2008 Aug; 52(2):151-60. PubMed ID: 18670364
[TBL] [Abstract][Full Text] [Related]
9. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary bypass-induced inflammation: is it important?
Hill GE
J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):21-5. PubMed ID: 9583572
[TBL] [Abstract][Full Text] [Related]
11. Is the heart a source for elevated circulating endothelin levels during aorta-coronary artery bypass grafting surgery in human beings?
Hasdai D; Erez E; Gil-Ad I; Raanani E; Sclarovsky S; Barak Y; Sulkes J; Vidne BA
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):531-6. PubMed ID: 8751523
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil adherence to isolated adult cardiac myocytes. Induction by cardiac lymph collected during ischemia and reperfusion.
Youker K; Smith CW; Anderson DC; Miller D; Michael LH; Rossen RD; Entman ML
J Clin Invest; 1992 Feb; 89(2):602-9. PubMed ID: 1346618
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress during reperfusion of human hearts: potential sources of oxygen free radicals.
Curello S; Ceconi C; de Giuli F; Panzali AF; Milanesi B; Calarco M; Pardini A; Marzollo P; Alfieri O; Messineo F
Cardiovasc Res; 1995 Jan; 29(1):118-25. PubMed ID: 7895229
[TBL] [Abstract][Full Text] [Related]
14. Deep hypothermic circulatory arrest and global reperfusion injury: avoidance by making a pump prime reperfusate--a new concept.
Allen BS; Veluz JS; Buckberg GD; Aeberhard E; Ignarro LJ
J Thorac Cardiovasc Surg; 2003 Mar; 125(3):625-32. PubMed ID: 12658205
[TBL] [Abstract][Full Text] [Related]
15. The role of neutrophils in myocardial ischemia-reperfusion injury.
Jordan JE; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1999 Sep; 43(4):860-78. PubMed ID: 10615413
[TBL] [Abstract][Full Text] [Related]
16. Molecular evidence for a border zone vulnerable to inflammatory reperfusion injury.
Youker KA; Hawkins HK; Kukielka GL; Perrard JL; Michael LH; Ballantyne CM; Smith CW; Entman ML
Trans Assoc Am Physicians; 1993; 106():145-54. PubMed ID: 7913564
[TBL] [Abstract][Full Text] [Related]
17. [Targeted combination and anti-inflammatory effects of anti-intercellular adhesion molecule 1 targeted perfluorooctylbromide particles on myocardial ischemia-reperfusion injury in rat model].
Shang Y; Tang H; Wei X; Hou J; Wang L; Li G; Song H; Fang H
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Mar; 27(3):340-4. PubMed ID: 23672138
[TBL] [Abstract][Full Text] [Related]
18. Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion.
Ko W; Hawes AS; Lazenby WD; Calvano SE; Shin YT; Zelano JA; Antonacci AC; Isom OW; Krieger KH
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):297-308. PubMed ID: 1865703
[TBL] [Abstract][Full Text] [Related]
19. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFkappaB binding site: evidence for a role of NFkappaB in ischemia-reperfusion injury.
Sawa Y; Morishita R; Suzuki K; Kagisaki K; Kaneda Y; Maeda K; Kadoba K; Matsuda H
Circulation; 1997 Nov; 96(9 Suppl):II-280-4; discussion II-285. PubMed ID: 9386111
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury.
Boyle EM; Kovacich JC; Hèbert CA; Canty TG; Chi E; Morgan EN; Pohlman TH; Verrier ED
J Thorac Cardiovasc Surg; 1998 Jul; 116(1):114-21. PubMed ID: 9671905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
